Note worthy news featured in this edition include:

• Anna Chodos and Beatrice Mullington retire
• Final requirements for HDAP submissions
• Online Filing of Form 2 – Project Update
• CPI-Based Price-Adjustment Factors for 2015
• The Hearing Panel approved a VCU in the Teva Canada Innovation G.P-S.E.N.C. and the medicine Copaxone matter
• New Publication – NPDUIS Research Study
• Summary of the Board’s April 23, 2014 Meeting

For more information, please see the April 2014 issue of the PMPRB NEWSletter.